Literature DB >> 2744940

Effect of IOP on the visual field in ocuLar hypertension and glaucoma.

A Heijl1.   

Abstract

The traditional opinion that increased intraocular pressure is the cause of glaucoma is controversial, probably mainly because of the fact that firm evidence for the value of pressure reduction is largely lacking. The present article reviews results from short term studies of visual fields before and after pressure reduction. It also reviews published and unpublished preliminary results from studies addressing the problem of whether the long term visual field prognosis, in glaucoma and in ocular hypertension, is affected by pressure lowering therapy. There is no convincing agreement among results from modern studies using computerized perimetry indicating that acute lowering of the ocular tension results in an improvement of the glaucomatous visual field. Long-term result are equally conflicting, and often negative. We have noted from a preliminary analysis of our own masked, prospective study of patients with 'high risk' ocular hypertension, that the same results may be interpreted in quite different ways. The results of available studies certainly indicate that pressure reduction does not automatically lead to clear and positive effects on the visual field. The studies have often been small, however, and have usually not had the power of detecting small effects of treatment. Also, pressure reduction has usually not been dramatic and many treated patients have maintained 'elevated' pressure levels. Patients with very high pressures have not been included, and the effect of pressure reduction in this situation has therefore not been investigated at all. More controlled, prospective therapeutic studies are necessary and ethical. It seems particularly important to study the long-term effects of non-pharmacologically induced pressure reduction in patients with manifest field loss.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2744940     DOI: 10.1007/bf02028651

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  20 in total

1.  Studies in the susceptibility of the eye to raised intraocular pressure.

Authors:  S M DRANCE
Journal:  Arch Ophthalmol       Date:  1962-10

2.  The effect of perimetric experience in normal subjects.

Authors:  A Heijl; G Lindgren; J Olsson
Journal:  Arch Ophthalmol       Date:  1989-01

3.  Pre-and post-operative results of static perimetry in patients with glaucoma simplex.

Authors:  E L Greve; C L Dake; W M Verduin
Journal:  Doc Ophthalmol       Date:  1977-02-28       Impact factor: 2.379

4.  Treatment versus no treatment in chronic open angle glaucoma.

Authors:  C Holmin; W Thorburn; C E Krakau
Journal:  Acta Ophthalmol (Copenh)       Date:  1988-04

5.  The effect of change in intraocular pressure on the natural history of glaucoma: lowering intraocular pressure in glaucoma can result in improvement of visual fields.

Authors:  G L Spaeth
Journal:  Trans Ophthalmol Soc U K       Date:  1985

6.  Effect of intravenous acetazolamide on relative arcuate scotomas and visual field in glaucoma simplex.

Authors:  G Paterson
Journal:  Proc R Soc Med       Date:  1970-09

7.  Experimental glaucoma in the rhesus monkey.

Authors:  D Gaasterland; C Kupfer
Journal:  Invest Ophthalmol       Date:  1974-06

8.  Short term effects of timolol in chronic glaucoma. A double blind study using computerized perimetry.

Authors:  C Holmin; C E Krakau
Journal:  Acta Ophthalmol (Copenh)       Date:  1982-06

9.  Effect of acetazolamide on the differential threshold.

Authors:  J Flammer; S M Drance
Journal:  Arch Ophthalmol       Date:  1983-09

10.  Long-term epinephrine therapy of ocular hypertension.

Authors:  D H Shin; A E Kolker; M A Kass; M B Kaback; B Becker
Journal:  Arch Ophthalmol       Date:  1976-12
View more
  1 in total

1.  The influence of different intraocular pressure on lamina cribrosa parameters in glaucoma and the relation clinical implication.

Authors:  Jian Wu; Yifan Du; Jiaying Li; Xiaowei Fan; Caixia Lin; Ningli Wang
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.